Orthopaedic Research UK

What Orthopaedic Research UK does

Orthopaedic Research UK (ORUK) is a UK registered charity (No. 1111657) and company limited by guarantee (No. 5585452) headquartered at Furlong House, 10a Chandos Street, London. The organisation funds innovative research into musculoskeletal (MSK) conditions, delivers CPD-accredited professional education to orthopaedic surgeons, clinicians, and allied health professionals, and operates programmes that translate academic MSK research into commercial products. Since 2004 ORUK reports investing £19,567,949 into research across 236 projects, supporting 725 researchers and clinicians and training 17,662 healthcare professionals through 266 educational events staged since September 2020.

ORUK's core products fall into three buckets. Research funding includes the Early Career Research Fellowship (up to £65K), specialty-society co-funded fellowships (BHS/ORUK up to £120K, BASK/ORUK up to £130K, BASS/BSS/ORUK up to £70K, BIOS/ORUK PPRF up to £20K, BAJIS/ORUK up to £6K), the Versus Arthritis/Kennedy Trust/ORUK Research Facilitation Fund (£250K-£650K), and the OBB Research Fund for medical students (up to £1,500). Innovation support includes the Ronald Furlong Fund (up to £100K impact investment with equity) and the ORUK MSK Accelerator at Imperial College London's MedTech SuperConnector. Education is delivered via an Online Learning Library with on-demand CPD courses approved by the Royal College of Surgeons of Edinburgh, FRCS exam preparation publications, and a calendar of conferences including FRCS revision courses and a 2025 AI in Orthopaedics conference. Operational infrastructure comprises the ORUK Grant Platform (GoodGrants-based) for application management and Researchfish for research output capture. ORUK holds equity in spin-outs Renovos (Renovite® nanoclay bone regeneration gel) and Radii Devices (prosthetics fit), and is a joint-venture partner with Embryo Ventures in Novara Therapeutics (patented gadolinium-tagged contrast agent for bone microfracture diagnosis and treatment).

ORUK's revenue model is donations-led: individual giving (preset £10-£100 or custom), legacy and property/share donations with associated UK tax reliefs, event registration fees (e.g. £10 for the BOTA x ORUK Sustainability in Orthopaedics virtual conference, free for medical students), and impact-investment returns on its equity portfolio. Distribution is primarily direct through the oruk.org website and grant platform, augmented by 13+ co-funding partnerships with UK professional societies (BOA, RCSEd, RCS England, BHS, BASK, BSSH, BASS, BSS, BIOS, BAJIS, BOFAS, GIRFT) and NIHR. Customer segments span MSK healthcare professionals, medical students and foundation doctors, early-career researchers, MSK startups/entrepreneurs, researchers returning from career breaks, and academic institutions/NHS trusts. Headcount is 1-10, consistent with a lean grant-making and convening operation rather than a clinical or commercial enterprise.

Name

Orthopaedic Research UK

Legal name

Orthopaedic Research UK

Website

https://oruk.org

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1–10 employees

Short description

Orthopaedic Research UK is a UK charity that funds musculoskeletal research projects, delivers CPD-accredited education to orthopaedic clinicians, and backs MSK startups through impact investment and the Imperial College-based MSK Innovation Accelerator.

Ownership category

akta.pro rank

Product category

Medical Research Charity Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Industry & Sector Research (Syndicated/Custom) (BPAHALAE)

akta.pro secondary industry

Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)

Keywords

• Musculoskeletal research funding
• Orthopaedic education
• Medical charity grants
• MSK professional development
• Healthcare innovation accelerator

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Others, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Donations and Charitable Giving: ORUK operates as a UK registered charity (No. 1111657) that relies on donations from individuals, organisations, and fundraising campaigns to fund its research and education programmes. All proceeds from donations go directly to ORUK research funds.
2. Event Registration Fees: Revenue generated from educational events, courses, and conferences. For example, the BOTA x ORUK Sustainability in orthopaedic surgery virtual conference charged £10 for standard registration. On-demand course sales are also a revenue stream, though no refunds are provided for failure to watch material.
3. Legacy Giving and Property Donations: ORUK accepts donations of land, property, and shares. Donors of property or shares are eligible for full tax relief from income and capital gains tax.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Orthopaedic Research UK (ORUK) is a UK medical research charity that funds innovative musculoskeletal (MSK) research projects, delivers CPD-approved professional education programmes, and supports the translation of research into commercial innovations. It provides research grants and fellowships (such as the Early Career Research Fellowship and Ronald Furlong Fund impact investment), runs educational events and an online learning library accredited by the Royal College of Surgeons of Edinburgh, and operates the ORUK MSK Accelerator at Imperial College London.

Product overview

Orthopaedic Research UK (ORUK) is a UK medical charity that advances musculoskeletal (MSK) health through research funding, professional education, and innovation support. The core offering is a portfolio of research funding programs including the Early Career Research Fellowship (up to £65K) and the Ronald Furlong Fund (up to £100K impact investment for startups), complemented by the ORUK MSK Accelerator in partnership with Imperial College London. Education is delivered through the Online Learning Library (CPD-approved courses), publications including FRCS exam preparation books, and staging of educational events. ORUK supports innovation translation through joint venture holdings including Renovite® (bone regeneration gel from Southampton University spinout Renovos) and Novara Therapeutics (bone microfracture diagnostic/treatment). Grant management infrastructure includes the ORUK Grant Platform for applications and progress tracking, and Researchfish for research output reporting. The organization also accepts charitable donations through its website.

Differentiator

Problem solved

Functional benefit

Products and services

• Early Career Research Fellowship Provides up to £65K over one year (or longer if Less Than Full Time) to support early-career clinical and non-clinical researchers pursuing MSK research and establishing academic independence.
• Ronald Furlong Fund Impact investment of up to £100K supporting UK-registered startups developing commercially viable MSK innovations; ORUK takes equity in the funded company.
• ORUK MSK Accelerator Six-month intensive accelerator programme at Imperial College London's MedTech SuperConnector offering entrepreneurship training, masterclasses, mentorship, and access to expertise, with opportunities to pitch for up to £100K investment from the ORUK Investment Committee.
• Online Learning Library On-demand courses and webinars providing CPD-approved professional development for MSK professionals.
• Educational Events and Courses Educational events, webinars, and courses staged for the MSK professional community, including FRCS (Tr and Orth) revision courses and specialty conferences such as the BOTA x ORUK Sustainability in orthopaedic surgery virtual conference.
• FRCS (Orth) Publications Books and educational publications designed to prepare candidates for FRCS (Orth) examinations and support MSK professional learning.
• Charitable Research Donation Charitable donation mechanism allowing individuals and organisations to contribute preset amounts (£10–£100) or custom amounts to ORUK research funds, with optional Gift Aid for UK taxpayers.
• ORUK Grant Platform Online platform (oruk.grantplatform.com) using GoodGrants technology for submission of funding applications, progress tracking of applications and projects, and submission of interim and final reports for grant recipients.

Quantifiable outcome

• £12,328,495 invested in research to date
• +4 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature3 records

Partnerships

21 partnerships are on record, tiered core and minor.

• Southampton University (Renovos spin-off)coreStrategic or Co-development PartnerORUK invested in Renovos, a spin-off from Southampton University pioneering the use of nanoclay in injectable gel form (Renovite®) for bone tissue regeneration. ORUK funding supports pre-clinical testing of this technology.
• Novara TherapeuticscoreStrategic or Co-development PartnerJoint venture company created with ORUK and Embryo Ventures to commercialise the world's first patented bio-specific solution for targeted diagnosis and treatment of bone microfractures. Builds on research from Brighton University, Newcastle University, and University of Milan.
• Zimmer-BiometcoreStrategic or Co-development PartnerPartner company in the development of the hybrid Layer-by-Layer deposition system for antibacterial coatings on orthopaedic implants. Zimmer-Biomet provided feedback on regulations, industry expertise, and business development support.
• British Orthopaedic Association (BOA)coreStrategic or Co-development PartnerJoint funding partner for the BOA/ORUK Research Fellowship aimed at developing a pipeline of research-active orthopaedic surgeons. Partnership extends ORUK's reach to BOA's membership network.
• Royal College of Surgeons of Edinburgh (RCSEd)coreStrategic or Co-development PartnerJoint funding partner for the Joint RCSEd-ORUK Research Fellowship in Orthopaedic Surgery. ORUK's education programmes have CPD approval from RCSEd, extending credibility and reach.
• Royal College of Surgeons of England (RCS England)coreStrategic or Co-development PartnerJoint funding partner for the Joint NJR/ORUK/RCS England Research Fellowship. RCS England provides employment and remuneration for fellows while ORUK co-funds the research.
• British Hip Society (BHS)coreStrategic or Co-development PartnerJoint funding partner for BHS/ORUK Research Fellowship offering up to £120k for 2-year full-time research fellowship focused on hip surgery research, particularly sustainability in hip surgery.
• British Association for Surgery of the Knee (BASK)coreStrategic or Co-development PartnerJoint funding partner for BASK/ORUK Research Fellowship offering up to £130k for 2-year research fellowship focused on knee-related research including AI, digital aids, and specific knee conditions.
• British Society for Surgery of the Hand (BSSH)coreStrategic or Co-development PartnerJoint funding partner for BSSH/ORUK Hand Research Fellowship promoting and developing hand surgery researchers and academics by supporting trainees and SAS surgeons.
• British Scoliosis Society (BSS) and British Association of Spine Surgeons (BASS)coreStrategic or Co-development PartnerJoint funding partners for BASS/BSS/ORUK Research Fellowship offering up to £70k for 2-year spine research fellowship aimed at individuals with interest in spinal research.
• British Indian Orthopaedic Society (BIOS)minorStrategic or Co-development PartnerJoint funding partner for BIOS/ORUK Pump-Prime Research Fund (PPRF) offering up to £20,000 split between 2 projects for early studies and pilot studies in trauma and orthopaedic surgery.
• Bone & Joint Infection Society (BAJIS)minorStrategic or Co-development PartnerJoint funding partner for BAJIS/ORUK Pump Priming Research Scheme offering up to £6,000 for one award over 1 year to support researchers developing academic skills in musculoskeletal infections.
• Versus Arthritis and Kennedy TrustcoreStrategic or Co-development PartnerJoint funding partnership for Research Facilitation Fund 2025 Round 2, providing £250,000-£650,000 for patient and public involvement (PPI) activity in musculoskeletal research across the UK.
• British Orthopaedic Trainees Association (BOTA) and British Orthopaedic Medical Students Association (BOMSA)coreStrategic or Co-development PartnerJoint funding partners for OBB Research Fund offering up to £1,500 for medical students and foundation year doctors, and Inspiration Fund offering up to £500 for research activities.
• The Daphne Jackson TrustcoreStrategic or Co-development PartnerJoint fellowship partner since 2023 supporting researchers returning to MSK research after career breaks due to illness, caring or family responsibilities. The fellowship includes financial support, retraining and mentoring.
• Getting It Right First Time (GIRFT) and British Orthopaedic Foot and Ankle Society (BOFAS)minorStrategic or Co-development PartnerPartnership for Foot and Ankle Senior Clinical Fellow position focused on service delivery models for foot and ankle surgery across England, hosted by Northumbria Healthcare.
• Imperial College London (MedTech SuperConnector)coreStrategic or Co-development PartnerORUK MSK Accelerator based within Imperial College London's MedTech SuperConnector, providing entrepreneurship training, masterclasses, and access to expertise for early-stage MSK innovators. Over £80,000 worth of academic and commercialisation support.
• NIHR (National Institute for Health & Care Research)coreStrategic or Co-development PartnerORUK is an NIHR RDN Non-commercial Partner, meaning funded studies may be eligible to access the NIHR Study Support Service provided by the NIHR Research Delivery Network.
• NIHR Invention for Innovation (i4i) ProgrammecoreStrategic or Co-development PartnerORUK co-funds research applications in the NIHR i4i Product Development Award calls to transform MSK health outcomes through application of emerging technologies including AI, digital health, VR, AR, and robotics.
• ARMA (Arthritis and Musculoskeletal Alliance)minorStrategic or Co-development PartnerORUK works with ARMA as part of its strategy to champion innovative ideas and collaborate with aligned charities in the musculoskeletal sector.
• King's FundminorOthersVenue partner for ORUK events including the London Basic Science FRCS revision course held at 11 Cavendish Square, London (Home of the King's Fund).

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Bone & Joint Initiative USA: US collaborative initiative advancing MSK health through research, education, and advocacy. Comparable as a multi-stakeholder MSK research and education platform, but operates in a different geography and funding model.
• Arthritis Research Canada: Canadian MSK research charity conducting clinical and applied research to improve arthritis care. Comparable as a charity-led MSK research organisation, though smaller in funding scale than ORUK's UK operations.

Broad incumbents

• Wellcome Trust: One of the world's largest charitable foundations funding biomedical research and innovation. A broad incumbent whose health innovation grants overlap with ORUK's MSK research and translation mission, but at vastly greater scale.
• Medical Research Council (MRC): UK national public funder of medical research including MSK-related work. Broader incumbent with vastly larger budget and remit, but competes for the same research talent pool and frequently co-funds with disease-specific charities like ORUK.
• National Institute for Health and Care Research (NIHR): UK government-funded health and social care research funder. Established NIHR RDN Non-commercial Partner relationship with ORUK and co-funds i4i Product Development Awards in MSK. Comparable as a research funding entity, but much broader in scope.

Direct peers

• Orthopaedic Research and Education Foundation (OREF): US-based non-profit funding orthopaedic research, education, and clinical practice advancement. Comparable as a national charity exclusively focused on funding orthopaedic/MSK research and researcher grants.
• Royal College of Surgeons of Edinburgh (RCSEd): UK surgical professional body that approves ORUK's CPD programmes and co-funds the Joint RCSEd-ORUK Research Fellowship. Overlapping role in MSK surgical education, training, and research funding.
• British Orthopaedic Association (BOA): UK professional membership body for orthopaedic surgeons and a long-standing ORUK co-funding partner (BOA/ORUK Research Fellowship). Overlapping constituency and shared funding programmes make it a directly comparable peer.
• Versus Arthritis: The UK's largest arthritis and musculoskeletal research charity, funding MSK research and patient support. Direct mission overlap with ORUK and an existing co-funding partner (Research Facilitation Fund). Comparable as a donor-funded MSK research charity with overlapping beneficiary base.
• Kennedy Trust for Rheumatology Research: UK charity funding rheumatology and MSK research, including the Kennedy Institute at Oxford. Direct peer on MSK research funding mission and existing ORUK co-funding partner (Research Facilitation Fund 2025).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/OR_UK
• YouTubeyoutube.com/channel/UCTdp4zqkTUfBnXvULl-G3mA
• Facebookfacebook.com/ORUKcharity
• LinkedInlinkedin.com/company/orthopaedic-research-uk-oruk-
• Instagraminstagram.com/or_uk

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Orthopaedic Research UK